• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The prevalence, risk factors and outcome of cardiac dysfunction in hospitalized patients with COVID-19.

作者信息

Li Yuman, Li He, Li Meng, Zhang Li, Xie Mingxing

机构信息

Department of Ultrasound, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1277# Jiefang Ave, Wuhan, 430022, China.

Hubei Province Key Laboratory of Molecular Imaging, Wuhan, 430022, China.

出版信息

Intensive Care Med. 2020 Nov;46(11):2096-2098. doi: 10.1007/s00134-020-06205-0. Epub 2020 Aug 7.

DOI:10.1007/s00134-020-06205-0
PMID:32767075
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7411264/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/090d/7411264/830f09b8e66f/134_2020_6205_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/090d/7411264/830f09b8e66f/134_2020_6205_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/090d/7411264/830f09b8e66f/134_2020_6205_Fig1_HTML.jpg

相似文献

1
The prevalence, risk factors and outcome of cardiac dysfunction in hospitalized patients with COVID-19.新型冠状病毒肺炎住院患者心脏功能障碍的患病率、危险因素及预后
Intensive Care Med. 2020 Nov;46(11):2096-2098. doi: 10.1007/s00134-020-06205-0. Epub 2020 Aug 7.
2
Risk factors for severe COVID-19: Evidence from 167 hospitalized patients in Anhui, China.重症新型冠状病毒肺炎的危险因素：来自中国安徽167例住院患者的证据。
J Infect. 2020 Jul;81(1):e89-e92. doi: 10.1016/j.jinf.2020.04.010. Epub 2020 Apr 17.
3
Clinical and laboratory-derived parameters of 119 hospitalized patients with coronavirus disease 2019 in Xiangyang, Hubei Province, China.中国湖北省襄阳市119例新型冠状病毒肺炎住院患者的临床及实验室指标
J Infect. 2020 Jul;81(1):147-178. doi: 10.1016/j.jinf.2020.03.038. Epub 2020 Apr 10.
4
Children hospitalized for coronavirus disease 2019 (COVID-19): A multicenter retrospective descriptive study.因2019冠状病毒病（COVID-19）住院的儿童：一项多中心回顾性描述性研究。
J Infect. 2020 Aug;81(2):e74-e75. doi: 10.1016/j.jinf.2020.04.045. Epub 2020 May 7.
5
Acute kidney injury in hospitalized patients with coronavirus disease 2019 (COVID-19): A meta-analysis.2019年冠状病毒病（COVID-19）住院患者的急性肾损伤：一项荟萃分析。
J Infect. 2020 Oct;81(4):647-679. doi: 10.1016/j.jinf.2020.05.009. Epub 2020 May 8.
6
Prevalence, Characteristics, and Outcome of Asthmatic Patients With Type 2 Diseases in Hospitalized Patients With COVID-19 in Madrid, Spain.西班牙马德里新冠肺炎住院患者中合并2型疾病的哮喘患者的患病率、特征及结局
J Investig Allergol Clin Immunol. 2020;30(5):382-384. doi: 10.18176/jiaci.0627. Epub 2020 Jun 18.
7
Hospitalized COVID-19 Patients and Venous Thromboembolism: A Perfect Storm.住院的新冠肺炎患者与静脉血栓栓塞：一场完美风暴。
Circulation. 2020 Jul 14;142(2):129-132. doi: 10.1161/CIRCULATIONAHA.120.048020. Epub 2020 Jul 13.
8
Identification and management of asymptomatic carriers of coronavirus disease 2019 (COVID-19) in China.中国2019冠状病毒病（COVID-19）无症状感染者的发现与管理
Influenza Other Respir Viruses. 2020 Sep;14(5):599-600. doi: 10.1111/irv.12768. Epub 2020 Jun 8.
9
Heartbeat: Heart disease and COVID-19.心跳：心脏病与2019冠状病毒病
Heart. 2020 Aug;106(15):1115-1116. doi: 10.1136/heartjnl-2020-317674.
10
Caring for cardiac patients amidst the SARS-CoV-2 pandemic: The scrambled pieces of the puzzle.在2019冠状病毒病大流行期间护理心脏病患者：拼图的杂乱碎片。
Rev Port Cardiol (Engl Ed). 2020 May;39(5):299-301. doi: 10.1016/j.repc.2020.04.008. Epub 2020 Apr 23.

引用本文的文献

1
The Role of Hand-Held Cardiac Ultrasound in Patients with COVID-19.手持式心脏超声在新冠病毒肺炎患者中的作用
Biomedicines. 2023 Jan 17;11(2):239. doi: 10.3390/biomedicines11020239.
2
Risk of mortality in COVID-19 patients: a meta- and network analysis.COVID-19 患者的死亡风险：荟萃分析和网络分析。
Sci Rep. 2023 Feb 6;13(1):2138. doi: 10.1038/s41598-023-29364-8.
3
Innate immune recognition against SARS-CoV-2.针对严重急性呼吸综合征冠状病毒2（SARS-CoV-2）的天然免疫识别

本文引用的文献

1
Facing COVID-19 in the ICU: vascular dysfunction, thrombosis, and dysregulated inflammation.重症监护病房中应对新型冠状病毒肺炎：血管功能障碍、血栓形成与炎症失调
Intensive Care Med. 2020 Jun;46(6):1105-1108. doi: 10.1007/s00134-020-06059-6. Epub 2020 Apr 28.
2
Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China.基于对来自中国武汉的150名患者数据的分析得出的COVID-19相关死亡的临床预测因素。
Intensive Care Med. 2020 May;46(5):846-848. doi: 10.1007/s00134-020-05991-x. Epub 2020 Mar 3.
3
Evaluation and Management of Right-Sided Heart Failure: A Scientific Statement From the American Heart Association.
Inflamm Regen. 2023 Jan 26;43(1):7. doi: 10.1186/s41232-023-00259-5.
4
Pulmonary hypertension at admission predicts ICU mortality in elderly critically ill with severe COVID-19 pneumonia: retrospective cohort study.入院时的肺动脉高压可预测重症 COVID-19 肺炎老年危重症患者 ICU 死亡率：回顾性队列研究。
Cardiovasc Ultrasound. 2023 Jan 18;21(1):1. doi: 10.1186/s12947-023-00300-0.
5
Polyoxygenated Terpenoids and Polyketides from the Roots of and Their Inhibitory Effect against SARS-CoV-2-Induced Inflammation.和根部分离得到的多氧萜类化合物和聚酮类化合物及其对 SARS-CoV-2 诱导的炎症的抑制作用。
Molecules. 2022 Dec 5;27(23):8548. doi: 10.3390/molecules27238548.
6
Influenza A virus modulates ACE2 expression and SARS-CoV-2 infectivity in human cardiomyocytes.甲型流感病毒调节人心肌细胞中ACE2的表达及新型冠状病毒2的感染性。
iScience. 2022 Dec 22;25(12):105701. doi: 10.1016/j.isci.2022.105701. Epub 2022 Dec 2.
7
Impactful publications of critical care medicine research in China: A bibliometric analysis.中国重症医学研究的影响力出版物：一项文献计量分析。
Front Med (Lausanne). 2022 Oct 18;9:974025. doi: 10.3389/fmed.2022.974025. eCollection 2022.
8
Clinical outcomes of COVID-19 patients with rheumatic diseases: a retrospective cohort study and synthesis analysis in Wuhan, China.COVID-19 患者合并风湿病的临床结局：一项中国武汉的回顾性队列研究和综合分析。
Clin Rheumatol. 2022 Jun;41(6):1899-1910. doi: 10.1007/s10067-022-06086-2. Epub 2022 Feb 16.
9
Echocardiographic 60-day mortality markers in patients hospitalized in intensive care for COVID-19.新冠肺炎患者重症监护住院 60 天心脏超声死亡标志物。
Heart Lung. 2022 Mar-Apr;52:123-129. doi: 10.1016/j.hrtlng.2021.12.007. Epub 2022 Jan 3.
10
The Utility of Handheld Cardiac and Lung Ultrasound in Predicting Outcomes of Hospitalised Patients With COVID-19.手持式心肺超声在预测 COVID-19 住院患者结局中的应用。
Can J Cardiol. 2022 Mar;38(3):338-346. doi: 10.1016/j.cjca.2021.11.016. Epub 2021 Dec 3.
右心衰竭的评估与管理：美国心脏协会的科学声明。
Circulation. 2018 May 15;137(20):e578-e622. doi: 10.1161/CIR.0000000000000560. Epub 2018 Apr 12.
4
2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines.2013年美国心脏病学会基金会/美国心脏协会心力衰竭管理指南：执行摘要：美国心脏病学会基金会/美国心脏协会实践指南工作组报告
Circulation. 2013 Oct 15;128(16):1810-52. doi: 10.1161/CIR.0b013e31829e8807. Epub 2013 Jun 5.